News

  • 19 January 2018

    NICE approves daratumumab use on NHS for myeloma

    The National Institute for Health and Care Excellence (NICE) has approved the use of immunotherapy drug daratumumab (Darzalex) on the National Health Service (NHS) for the treatment of myeloma patients...